Literature DB >> 10918821

[Constitutive activation of the ERK-MAP kinase pathway in human tumors].

R Hoshino1, M Kohno.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918821

Source DB:  PubMed          Journal:  Seikagaku        ISSN: 0037-1017


× No keyword cloud information.
  2 in total

1.  SPRY1 promotes the degradation of uPAR and inhibits uPAR-mediated cell adhesion and proliferation.

Authors:  Xiufeng Liu; Yan Lan; Di Zhang; Kai Wang; Yao Wang; Zi-Chun Hua
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

2.  Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.

Authors:  N Ahmed; K Oliva; Y Wang; M Quinn; G Rice
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.